Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingNot ApplicableIIT A Randomized Controlled Clinical Study on Jingzhi Niuhuang Jiedu Tablets in the Treatment of Epidemic Viral Influenza
Post-marketing evaluation of Xingxiao Pills: Real-world studies on the safety of Xingxiao pills in patients with tumors and nodules in the real world
Active monitoring after reevaluation of Maren Runchang softgel
100 Clinical Results associated with Beijing Tongrentang Technology Development Co., Ltd. Pharmaceutical Factory
0 Patents (Medical) associated with Beijing Tongrentang Technology Development Co., Ltd. Pharmaceutical Factory
100 Deals associated with Beijing Tongrentang Technology Development Co., Ltd. Pharmaceutical Factory
100 Translational Medicine associated with Beijing Tongrentang Technology Development Co., Ltd. Pharmaceutical Factory